{"id":"comparator-paroxetine-hcl","safety":{"commonSideEffects":[{"rate":"15-25%","effect":"Nausea"},{"rate":"10-20%","effect":"Headache"},{"rate":"10-15%","effect":"Insomnia"},{"rate":"10-15%","effect":"Somnolence"},{"rate":"10-20%","effect":"Sexual dysfunction"},{"rate":"5-10%","effect":"Tremor"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Sweating"}]},"_chembl":{"chemblId":"CHEMBL6067650","moleculeType":"Small molecule","molecularWeight":"749.68"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Paroxetine is a selective serotonin reuptake inhibitor (SSRI) that blocks the serotonin transporter protein, preventing the reabsorption of serotonin from the synaptic cleft back into presynaptic neurons. This increases serotonin concentration in the synapse, enhancing neurotransmission and improving mood regulation. It has minimal effects on other neurotransmitter systems compared to older antidepressants.","oneSentence":"Paroxetine HCl selectively inhibits the reuptake of serotonin at the neuronal synapse, increasing serotonin availability in the brain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:07:04.814Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder"},{"name":"Generalized anxiety disorder"},{"name":"Panic disorder"},{"name":"Obsessive-compulsive disorder"},{"name":"Post-traumatic stress disorder"},{"name":"Social anxiety disorder"}]},"trialDetails":[{"nctId":"NCT05730062","phase":"PHASE1","title":"Influence of Oxycodone on Individuals Taking an SSRI","status":"UNKNOWN","sponsor":"Leiden University Medical Center","startDate":"2023-03-15","conditions":"Opioid Induced Respiratory Depression, Depressive Disorder, Anxiety Disorders","enrollment":55},{"nctId":"NCT04404439","phase":"PHASE4","title":"Treatment of Tinnitus With Migraine Medications","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2019-09-26","conditions":"Tinnitus, Subjective, Tinnitus","enrollment":150},{"nctId":"NCT03277339","phase":"PHASE4","title":"Psycho-biological Substrates of Therapeutic Benefit of Thermal Cure on Generalized Anxiety Disorders","status":"COMPLETED","sponsor":"Centre Hospitalier Henri Laborit","startDate":"2017-01-19","conditions":"Generalized Anxious Disorders","enrollment":52},{"nctId":"NCT00641511","phase":"PHASE2","title":"Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD)","status":"WITHDRAWN","sponsor":"Michael E. DeBakey VA Medical Center","startDate":"2008-06","conditions":"Post Traumatic Stress Disorder (PTSD)","enrollment":""},{"nctId":"NCT00560612","phase":"PHASE4","title":"Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)","status":"COMPLETED","sponsor":"Durham VA Medical Center","startDate":"2006-01","conditions":"Stress Disorders, Post-Traumatic","enrollment":12},{"nctId":"NCT03504475","phase":"PHASE1","title":"Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers","status":"COMPLETED","sponsor":"Beijing Tongren Hospital","startDate":"2018-03-29","conditions":"Major Depressive Disorder, Obsessive-Compulsive Disorder, Panic Disorder","enrollment":53},{"nctId":"NCT00470483","phase":"PHASE1","title":"A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-01-22","conditions":"Social Phobia","enrollment":56},{"nctId":"NCT00048607","phase":"PHASE3","title":"Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2002-07-30","conditions":"Major Depressive Disorder","enrollment":600},{"nctId":"NCT00034983","phase":"PHASE3","title":"Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2001-10-29","conditions":"Major Depressive Disorder","enrollment":900},{"nctId":"NCT00035009","phase":"PHASE3","title":"Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2001-09-20","conditions":"Major Depressive Disorder","enrollment":468},{"nctId":"NCT02476136","phase":"","title":"Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis","status":"UNKNOWN","sponsor":"prof. Peter de Jonge","startDate":"2015-05","conditions":"Anxiety Disorders, Panic Disorder, Obsessive-compulsive Disorder","enrollment":8800},{"nctId":"NCT01318434","phase":"PHASE2, PHASE3","title":"A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)","status":"COMPLETED","sponsor":"Euthymics BioScience, Inc.","startDate":"2011-02","conditions":"Major Depressive Disorder","enrollment":342}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Comparator: paroxetine HCL","genericName":"Comparator: paroxetine HCL","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Paroxetine HCl selectively inhibits the reuptake of serotonin at the neuronal synapse, increasing serotonin availability in the brain. Used for Major depressive disorder, Generalized anxiety disorder, Panic disorder.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":3,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}